The global palm vein biometric market size is calculated at USD 817.90 million in 2025 and is forecasted to reach around USD 3,556.45 million by 2034, accelerating at a CAGR of 17.74% from 2025 to 2034. The North America market size surpassed USD 229.24 million in 2024 and is expanding at a CAGR of 17.91% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Palm Vein Biometric Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Palm Vein Biometric Market Revenue and Volume Forecast, by Technology
8.1.1. Contact-Based
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Contactless
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Hybrid
8.1.3.1. Market Revenue and Volume Forecast
9.1. Palm Vein Biometric Market Revenue and Volume Forecast, by Component
9.1.1. Hardware
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Software
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Services
9.1.3.1. Market Revenue and Volume Forecast
10.1. Palm Vein Biometric Market Revenue and Volume Forecast, by Application
10.1.1. Healthcare
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Banking
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Security Systems
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Security Systems
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Automated Attendance
10.1.5.1. Market Revenue and Volume Forecast
11.1. Palm Vein Biometric Market Revenue and Volume Forecast, by End Use
11.1.1. Commercial
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Government
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Residential
11.1.3.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Technology
12.1.2. Market Revenue and Volume Forecast, by Component
12.1.3. Market Revenue and Volume Forecast, by Application
12.1.4. Market Revenue and Volume Forecast, by End Use
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Technology
12.1.5.2. Market Revenue and Volume Forecast, by Component
12.1.5.3. Market Revenue and Volume Forecast, by Application
12.1.5.4. Market Revenue and Volume Forecast, by End Use
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Technology
12.1.6.2. Market Revenue and Volume Forecast, by Component
12.1.6.3. Market Revenue and Volume Forecast, by Application
12.1.6.4. Market Revenue and Volume Forecast, by End Use
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Technology
12.2.2. Market Revenue and Volume Forecast, by Component
12.2.3. Market Revenue and Volume Forecast, by Application
12.2.4. Market Revenue and Volume Forecast, by End Use
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Technology
12.2.5.2. Market Revenue and Volume Forecast, by Component
12.2.5.3. Market Revenue and Volume Forecast, by Application
12.2.5.4. Market Revenue and Volume Forecast, by End Use
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Technology
12.2.6.2. Market Revenue and Volume Forecast, by Component
12.2.6.3. Market Revenue and Volume Forecast, by Application
12.2.6.4. Market Revenue and Volume Forecast, by End Use
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Technology
12.2.7.2. Market Revenue and Volume Forecast, by Component
12.2.7.3. Market Revenue and Volume Forecast, by Application
12.2.7.4. Market Revenue and Volume Forecast, by End Use
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Technology
12.2.8.2. Market Revenue and Volume Forecast, by Component
12.2.8.3. Market Revenue and Volume Forecast, by Application
12.2.8.4. Market Revenue and Volume Forecast, by End Use
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Technology
12.3.2. Market Revenue and Volume Forecast, by Component
12.3.3. Market Revenue and Volume Forecast, by Application
12.3.4. Market Revenue and Volume Forecast, by End Use
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Technology
12.3.5.2. Market Revenue and Volume Forecast, by Component
12.3.5.3. Market Revenue and Volume Forecast, by Application
12.3.5.4. Market Revenue and Volume Forecast, by End Use
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Technology
12.3.6.2. Market Revenue and Volume Forecast, by Component
12.3.6.3. Market Revenue and Volume Forecast, by Application
12.3.6.4. Market Revenue and Volume Forecast, by End Use
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Technology
12.3.7.2. Market Revenue and Volume Forecast, by Component
12.3.7.3. Market Revenue and Volume Forecast, by Application
12.3.7.4. Market Revenue and Volume Forecast, by End Use
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Technology
12.3.8.2. Market Revenue and Volume Forecast, by Component
12.3.8.3. Market Revenue and Volume Forecast, by Application
12.3.8.4. Market Revenue and Volume Forecast, by End Use
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Technology
12.4.2. Market Revenue and Volume Forecast, by Component
12.4.3. Market Revenue and Volume Forecast, by Application
12.4.4. Market Revenue and Volume Forecast, by End Use
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Technology
12.4.5.2. Market Revenue and Volume Forecast, by Component
12.4.5.3. Market Revenue and Volume Forecast, by Application
12.4.5.4. Market Revenue and Volume Forecast, by End Use
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Technology
12.4.6.2. Market Revenue and Volume Forecast, by Component
12.4.6.3. Market Revenue and Volume Forecast, by Application
12.4.6.4. Market Revenue and Volume Forecast, by End Use
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Technology
12.4.7.2. Market Revenue and Volume Forecast, by Component
12.4.7.3. Market Revenue and Volume Forecast, by Application
12.4.7.4. Market Revenue and Volume Forecast, by End Use
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Technology
12.4.8.2. Market Revenue and Volume Forecast, by Component
12.4.8.3. Market Revenue and Volume Forecast, by Application
12.4.8.4. Market Revenue and Volume Forecast, by End Use
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Technology
12.5.2. Market Revenue and Volume Forecast, by Component
12.5.3. Market Revenue and Volume Forecast, by Application
12.5.4. Market Revenue and Volume Forecast, by End Use
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Technology
12.5.5.2. Market Revenue and Volume Forecast, by Component
12.5.5.3. Market Revenue and Volume Forecast, by Application
12.5.5.4. Market Revenue and Volume Forecast, by End Use
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Technology
12.5.6.2. Market Revenue and Volume Forecast, by Component
12.5.6.3. Market Revenue and Volume Forecast, by Application
12.5.6.4. Market Revenue and Volume Forecast, by End Use
13.1. HID Global
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. IDEMIA
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. INFINIDAT
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Oak Ridge National Laboratory
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. SRI International
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. MorphoTrust USA
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Analogic
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. ZKTECO
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. BioSec Group
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Versasec
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample